JULIE BURKE: Open Payments
NPI 1366797391 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,714 in 200 payments from 14 companies in 2025. Trend: 2023 $922 · 2024 $9,876 · 2025 $64,714
Speaker / faculty: $59,500Travel & lodging: $2,862Food & beverage: $2,243Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 138 | $63,474 |
| Neurocrine BioSciences, Inc. | 14 | $282 |
| Otsuka America Pharmaceutical, Inc. | 11 | $177 |
| Axsome Therapeutics, Inc. | 6 | $177 |
| Teva Pharmaceuticals USA, Inc. | 6 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $161 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Biogen, Inc. | 1 | $27 |
Products named: VRAYLAR, INGREZZA, Auvelity, CAPLYTA, FANAPT, NUEDEXTA, AUSTEDO XR, REXULTI.
Industry payments across GA — which companies pay providers there.
